Reperfusion Approach in Predicted In-hospital Delay for Primary PCI in STEMI

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 240 participants.

Also called NCT07641231

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 240 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07641231
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Russia (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07641231. Randomized; no masking; primary purpose treatment. Start 2026-05-20 (anticipated); primary completion 2028-05-20 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Reperfusion Approach in Predicted In-hospital Delay for Primary PCI in STEMI
Acronym
RAPID-STEMI
Condition
STEMI - ST Elevation Myocardial Infarction
Intervention (Drug)
Single, weight-adjusted i.v. bolus of tenecteplase
Intervention (Procedure)
catheterisation
Lead sponsor
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation (class: other government)
Collaborator
AO GENERIUM (class: industry)

Record details

Record id
cardio:ct-nct07641231
Content hash
57d2601f64080d3efde483b17d59fafd0a78cf005e9ea3ba000b276fe11fd8ac